3 hours Ago By Defense World Staff
Invesco Ltd. trimmed its holdings in shares of Qiagen (NYSE:QGEN – Free Report) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
The fund owned 396,255 shares of the company’s stock after selling 24,297 shares during the quarter. Invesco Ltd. owned 0.
18% of Qiagen worth $17,645,000 at the end of the most recent reporting period. Other large investors have also recently made changes to their positions in the company. Brown Brothers Harriman & Co.
bought a new stake in Qiagen during the 4th quarter valued at $37,000. Geneos Wealth Management Inc. increased its stake in shares of Qiagen by 41.
5% during the fourth quarter. Geneos Wealth Management Inc. now owns 856 shares of the company’s stock valued at $38,000 after buying an additional 251 shares during the period.
EverSource Wealth Advisors LLC raised its holdings in shares of Qiagen by 152.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 871 shares of the company’s stock valued at $39,000 after acquiring an additional 526 shares in the last quarter.
Wilmington Savings Fund Society FSB purchased a new stake in Qiagen in the third quarter worth about $53,000. Finally, Smartleaf Asset Management LLC lifted its stake in Qiagen by 148.0% in the fourth quarter.
Smartleaf Asset Management LLC now owns 1,399 shares of the company’s stock worth $63,000 after acquiring an additional 835 shares during the period. 70.00% of the stock is owned by hedge funds and other institutional investors.
Qiagen Stock Up 4.6 %Qiagen stock opened at $42.33 on Wednesday.
Qiagen has a 1-year low of $37.63 and a 1-year high of $49.30.
The business has a fifty day moving average price of $39.80 and a 200-day moving average price of $41.71.
The company has a debt-to-equity ratio of 0.38, a current ratio of 3.61 and a quick ratio of 3.
09. The stock has a market capitalization of $9.41 billion, a price-to-earnings ratio of 117.
87, a PEG ratio of 2.39 and a beta of 0.62.
Qiagen (NYSE:QGEN – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.
60 by $0.01. Qiagen had a return on equity of 13.
92% and a net margin of 4.23%. Equities research analysts forecast that Qiagen will post 2.
26 EPS for the current fiscal year. Analyst Ratings ChangesQGEN has been the subject of several recent research reports. Morgan Stanley restated an “equal weight” rating and issued a $46.
67 price target (down previously from $48.61) on shares of Qiagen in a report on Monday, January 6th. UBS Group reduced their price objective on shares of Qiagen from $50.
00 to $48.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Baird R W cut Qiagen from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 19th.
Robert W. Baird lifted their price target on Qiagen from $42.00 to $43.
00 and gave the company a “neutral” rating in a report on Monday. Finally, Redburn Atlantic cut Qiagen from a “buy” rating to a “neutral” rating in a research note on Friday, April 4th. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.
According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $47.83.Read Our Latest Stock Report on QGENAbout Qiagen (Free Report)QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.Read MoreFive stocks we like better than QiagenDo ETFs Pay Dividends? What You Need to KnowHow to Invest in Micro-Cap Stocks Like a ProESG Stocks, What Investors Should KnowInvestors Sell Microsoft Stock on OpenAI News—Time to Buy? Stock Trading Terms – Stock Terms Every Investor Needs to KnowTake-Two Interactive: A Defensive Play Set to ExplodeWant to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen (NYSE:QGEN – Free Report).
.
